Danone Sa · EURONEXT:BN

Danone Sa — Kepler Cheuvreux Autumn Conference 2013

29 slides from Danone Sa's conference presentation, Sep 18, 2013

  1. Slide 1: Kepler Cheuvreux Autumn Conference, Paris

    Pierre-André Terisse Chief Financial Officer Kepler Cheuvreux - Autumn Conference Paris – September 18th, 2013

  2. Slide 2: Disclaimer

    Disclaimer This document contains certain forward-looking statements concerning DANONE. Although DANONE believes its expectations are based on reasonable assumptions, these forward-looking statements are subject to numerous risks and uncertainties, which could cause actual results to differ material

  3. Slide 3: A unique mission

    A unique mission BRING HEALTH THROUGH FOOD TO AS MANY PEOPLE AS POSSIBLE 3

  4. Slide 4: Clear priorities

    Clear priorities 2013 a year of transition 2014 back to Europe : Strong Adapt & fix – Savings & competitiveness – Value for consumers Growth markets : Invest & leverage 4

  5. Slide 5: H1 Results in line with priorities

    H1 Results in line with priorities H1 2013 Results figures Sales breakdown Growth Markets Europe Sales Sales 6.9 bn 4.2 bn +13.5% like-for-like(1) -4.0% like-for-like(1) 38% Trading operating margin 62% Trading operating margin 12.8% 14.3% +10bps like-for-like(1) -118bps like-for-like(1) (1) Like-fo

  6. Slide 6: Europe: First positive signals

    Europe : First positive signals EUROPE TOPLINE H1 2012 H2 2012 H1 2013 (1.7%) (4.5%) (4.0%) 6

  7. Slide 7: Europe: Our roadmap to restore growth

    Europe : Our roadmap to restore growth The best packaging The right The best organization product The right price point Differentiating innovation 7

  8. Slide 8: Dairy Europe: first signs of stabilization

    Dairy Europe : first signs of stabilization Breakdown volume / value growth (%) Value market shares Spain Portugal Italy France UK Germany Q4 12 Q1 13 Q2 13 8

  9. Slide 9: Plan for competitiveness in Europe moving on target

    Plan for competitiveness in Europe moving on target EUROPE – 26 countries ADAPT & SAVINGS SIMPLIFY & €200mln ORGANISATION & PROCESSES REGAIN COMPETITIVE EDGE 9

  10. Slide 10: Noram & CIS: Leveraging and building strong platforms

    Noram & CIS : Leveraging and building strong platforms TOPLINE 8.2% 9.3% 5.3% NORAM & CIS H1 2012 H2 2012 H1 2013 10

  11. Slide 11: Fresh Dairy US: Greek yogurt becoming a component of diet

    Fresh Dairy US : Greek yogurt becoming a component of Americans’diet Greek segment latest innovations Fresh Dairy products category Value market shares by segment Greek 46.5% Core 24.5% Light Competitor 1 Kids 12.5% 38.3% Greek yogurt segment Danone 9.3% Value market shares 30.6% 6.8% Active Health

  12. Slide 12: Strategic Agreement with Starbucks to develop yogurt consumption

    Strategic Agreement with Starbucks to develop yogurt consumption Create and Develop an Exclusive Line of Evolution Fresh, Inspired by Dannon- branded Fresh Dairy Products 2014 : Ready-to-eat Greek yogurt parfait in 11,000 U.S. Starbucks stores 2015 : Roll-out in U.S grocery channels Additional regio

  13. Slide 13: YoCrunch acquisition to access new segment

    YoCrunch acquisition to access new segment and expand offer Market leader in yogurts with toppings Co-branded originals A unique know-how in compartmentalized packaging Yo Crunch Developing the category by offering kids new ways to enjoy yogurt Sustained double-digit growth in recent years All famil

  14. Slide 14: ALMA: Leveraging platforms and preparing the future

    ALMA : Leveraging platforms and preparing the future TOPLINE ALMA 16.7% 15.9% 14.7% H1 2012 H2 2012 H1 2013 14

  15. Slide 15: ALMA: Leveraging platforms and preparing the future

    ALMA : Leveraging platforms and preparing the future Building and leveraging strong platforms Nurturing seeds for growth 15

  16. Slide 16: Fonterra: Precautionary recall in 8 markets

    Fonterra : Precautionnary recall in 8 markets 2nd August 2013 : some batches of whey protein concentrate supplied by Fonterra suspected of containing Clostridium Botulinum Danone immediately recalled all finished products potentially related to incriminated batches. Internal & external tests on reca

  17. Slide 17: Action plan to restore sales in recall countries – China

    Action plan to restore sales in recall countries – China example Sales in recall countries significantly impacted during recall TVC & press campains On pack sticker « Dumex is safe to use » « This pack is tested & cheked » Action plan to restore sales : Chinese example KMBS/NKA joint announcement :

  18. Slide 18: Waters Brazil: The next emerging market

    Waters Brazil : The next emerging market Bonafont – a market leader in Sao Paulo area 3x Competitor 1 Launch of HOD last year Competitor 2 Competitor 3 Set in 2009 2010 2011 2012 2013(E) 2008 Source: MT SHARE – VOLUME – IPANEL GSP 18

  19. Slide 19: Baby Brazil: Developing market from a challenger position

    Baby Brazil : Developing market from a challenger position 2007-2013 achievements 2007-2013 action plan DBN value market share 22.5% 21% 18% 15% Creating Category 13% Recognition (Credibility) 11% 7% Leading Category Innovation 2007 2008 2009 2010 2011 2012 YTD 2013 Improving Presence DBN Sales evol

  20. Slide 20: Baby India: Developing market from a challenger position

    Baby India : Developing market from a challenger position A PCC far below other Asian Countries Clear roadmap for integration & development Quality & sourcing Population 1.3 bn 240 mln 1.2 bn Relevance Births/year 15 mln 4 mln 25 mln Enriching HCPs with the right knowledge & services PCC IFFO 12 kg

  21. Slide 21: Dairy South Africa: Reaching more consumers

    Dairy South Africa : Reaching more consumers PCC potential down the Export to 10 countries pyramid Relevant innovation Sales evolution Ultramel : 7 months shelf-life Mayo (adults): +14% CAGR Nutriday : 3 months shelf-life 3 months shelf-life 2007 2008 2009 2010 2011 2012 2013e 21

  22. Slide 22: Conclusion

    DANONE CONCLUSION 22

  23. Slide 23: Plenty of growth opportunities for now and the future

    Plenty of growth opportunities for now and the future N° 2 Fresh Dairy N° 1 Waters N° 1 Fresh Dairy N° 1 Baby Nutrition N° 1 Medical Nutrition N° 1 Medical Nutrition N° 2 Baby Nutrition N°1 Fresh Dairy N° 1 Fresh Dairy N° 1 Fresh Dairy N° 1 Waters N° 1 Waters N° 1 Baby Nutrition N° 1 Baby Nutrition

  24. Slide 24: 2013 objectives

    2013 objectives 2013 objectives Sales growth (1) At least 5% Trading operating margin(1) -30bps to -50bps Free cash-flow excluding exceptional items (2)(3) Around € 2 bn (1) Like-for-like : Based on constant scope of consolidation and constant exchange rates (2) Free cash-flow excluding exceptional

  25. Slide 25: %. Kepler

    %. Kepler dV, Cheuvreux

  26. Slide 26: Notes

    ‘2 DANONE 26

  27. Slide 27: Notes

    ‘2 DANONE 27

  28. Slide 28: Notes

    ‘2 DANONE 28

  29. Slide 29: %. Kepler

    %. Kepler dV, Cheuvreux

Danone — Kepler Cheuvreux Autumn Conference 2013 on 6ix